Search This Blog

Monday, August 5, 2019

Krystal Biotech EPS misses by $0.05

Krystal Biotech (NASDAQ:KRYS): Q2 GAAP EPS of -$0.37 misses by $0.05.
Cash, cash equivalents and short-term investments of $195.5M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)